ACAD ACADIA Pharmaceuticals Inc

For the fiscal year ended 31/12/2022: ACADIA Pharmaceuticals Inc's revenues increased by 6.83% and amounted to 517.24M. Net income decreased by 28.66% to -215.98M. Net assets decreased by 25.97% to 400.41M and EPS decreased from -1.05 to -1.34.